641 related articles for article (PubMed ID: 27614981)
1. Application of LC-MS-based metabolomics method in differentiating septic survivors from non-survivors.
Liu Z; Yin P; Amathieu R; Savarin P; Xu G
Anal Bioanal Chem; 2016 Nov; 408(27):7641-7649. PubMed ID: 27614981
[TBL] [Abstract][Full Text] [Related]
2. Nuclear magnetic resonance-based serum metabolomic analysis reveals different disease evolution profiles between septic shock survivors and non-survivors.
Liu Z; Triba MN; Amathieu R; Lin X; Bouchemal N; Hantz E; Le Moyec L; Savarin P
Crit Care; 2019 May; 23(1):169. PubMed ID: 31088568
[TBL] [Abstract][Full Text] [Related]
3. Altered profiles of serum amino acids in patients with sepsis and septic shock - Preliminary findings.
Mierzchala-Pasierb M; Lipinska-Gediga M; Fleszar MG; Lesnik P; Placzkowska S; Serek P; Wisniewski J; Gamian A; Krzystek-Korpacka M
Arch Biochem Biophys; 2020 Sep; 691():108508. PubMed ID: 32712289
[TBL] [Abstract][Full Text] [Related]
4. Untargeted Metabolomics Differentiates l-Carnitine Treated Septic Shock 1-Year Survivors and Nonsurvivors.
Evans CR; Karnovsky A; Puskarich MA; Michailidis G; Jones AE; Stringer KA
J Proteome Res; 2019 May; 18(5):2004-2011. PubMed ID: 30895797
[TBL] [Abstract][Full Text] [Related]
5. Metabolic profiling of serum samples by 1H nuclear magnetic resonance spectroscopy as a potential diagnostic approach for septic shock.
Mickiewicz B; Duggan GE; Winston BW; Doig C; Kubes P; Vogel HJ;
Crit Care Med; 2014 May; 42(5):1140-9. PubMed ID: 24368342
[TBL] [Abstract][Full Text] [Related]
6. Integration of metabolic and inflammatory mediator profiles as a potential prognostic approach for septic shock in the intensive care unit.
Mickiewicz B; Tam P; Jenne CN; Leger C; Wong J; Winston BW; Doig C; Kubes P; Vogel HJ;
Crit Care; 2015 Jan; 19(1):11. PubMed ID: 25928796
[TBL] [Abstract][Full Text] [Related]
7. Development of chemical isotope labeling liquid chromatography mass spectrometry for silkworm hemolymph metabolomics.
Shen W; Han W; Li Y; Meng Z; Cai L; Li L
Anal Chim Acta; 2016 Oct; 942():1-11. PubMed ID: 27720112
[TBL] [Abstract][Full Text] [Related]
8. Mortality prediction in patients with severe septic shock: a pilot study using a target metabolomics approach.
Ferrario M; Cambiaghi A; Brunelli L; Giordano S; Caironi P; Guatteri L; Raimondi F; Gattinoni L; Latini R; Masson S; Ristagno G; Pastorelli R
Sci Rep; 2016 Feb; 6():20391. PubMed ID: 26847922
[TBL] [Abstract][Full Text] [Related]
9. Study of the metabolomics characteristics of patients with metabolic syndrome based on liquid chromatography quadrupole time-of-flight mass spectrometry.
Wu N; Wang W; Yi M; Cheng S; Wang D
Ann Endocrinol (Paris); 2018 Feb; 79(1):37-44. PubMed ID: 29246383
[TBL] [Abstract][Full Text] [Related]
10. Development of high-performance chemical isotope labeling LC-MS for profiling the human fecal metabolome.
Xu W; Chen D; Wang N; Zhang T; Zhou R; Huan T; Lu Y; Su X; Xie Q; Li L; Li L
Anal Chem; 2015 Jan; 87(2):829-36. PubMed ID: 25486321
[TBL] [Abstract][Full Text] [Related]
11. An analysis of urine and serum amino acids in critically ill patients upon admission by means of targeted LC-MS/MS: a preliminary study.
Mierzchała-Pasierb M; Lipińska-Gediga M; Fleszar MG; Lewandowski Ł; Serek P; Płaczkowska S; Krzystek-Korpacka M
Sci Rep; 2021 Oct; 11(1):19977. PubMed ID: 34620961
[TBL] [Abstract][Full Text] [Related]
12. Metabolomic Analysis Using Liquid Chromatography/Mass Spectrometry for Gastric Cancer.
Liang Q; Wang C; Li B
Appl Biochem Biotechnol; 2015 Aug; 176(8):2170-84. PubMed ID: 26088916
[TBL] [Abstract][Full Text] [Related]
13. A novel ion pairing LC/MS metabolomics protocol for study of a variety of biologically relevant polar metabolites.
Knee JM; Rzezniczak TZ; Barsch A; Guo KZ; Merritt TJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Oct; 936():63-73. PubMed ID: 24004912
[TBL] [Abstract][Full Text] [Related]
14. Prognosis Biomarkers of Severe Sepsis and Septic Shock by 1H NMR Urine Metabolomics in the Intensive Care Unit.
Garcia-Simon M; Morales JM; Modesto-Alapont V; Gonzalez-Marrachelli V; Vento-Rehues R; Jorda-Miñana A; Blanquer-Olivas J; Monleon D
PLoS One; 2015; 10(11):e0140993. PubMed ID: 26565633
[TBL] [Abstract][Full Text] [Related]
15. High-sensitive liquid chromatography-tandem mass spectrometry-based chiral metabolic profiling focusing on amino acids and related metabolites.
Nakano Y; Taniguchi M; Fukusaki E
J Biosci Bioeng; 2019 Apr; 127(4):520-527. PubMed ID: 30563742
[TBL] [Abstract][Full Text] [Related]
16. Optimization study for metabolomics analysis of human sweat by liquid chromatography-tandem mass spectrometry in high resolution mode.
Calderón-Santiago M; Priego-Capote F; Jurado-Gámez B; Luque de Castro MD
J Chromatogr A; 2014 Mar; 1333():70-8. PubMed ID: 24529403
[TBL] [Abstract][Full Text] [Related]
17. Global metabolic profiling using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry.
Qi Y; Song Y; Gu H; Fan G; Chai Y
Methods Mol Biol; 2014; 1198():15-27. PubMed ID: 25270920
[TBL] [Abstract][Full Text] [Related]
18. Tailored liquid chromatography-mass spectrometry analysis improves the coverage of the intracellular metabolome of HepaRG cells.
Cuykx M; Negreira N; Beirnaert C; Van den Eede N; Rodrigues R; Vanhaecke T; Laukens K; Covaci A
J Chromatogr A; 2017 Mar; 1487():168-178. PubMed ID: 28153450
[TBL] [Abstract][Full Text] [Related]
19. Serum metabolic profiles of septic shock patients based upon co-morbidities and other underlying conditions.
Pandey S; Adnan Siddiqui M; Azim A; Trigun SK; Sinha N
Mol Omics; 2021 Apr; 17(2):260-276. PubMed ID: 33399607
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
